MedPath

To explore safety and feasibility of mobile teledermoscopy for Queensland residents 50-64 year of age at high risk for melanoma.

Completed
Conditions
Skin CancerMelanoma
Skin Cancer
Melanoma
Cancer - Malignant melanoma
Registration Number
ACTRN12613000590763
Lead Sponsor
Queensland University of Technology (QUT), Institute of Health and Biomedical Innovation (IHBI)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

Inclusion criteria include: Male and female between 50-64 years of age in Queensland. Previous melanoma or skin cancer diagnosis, fair skin or high number of moles. In addition, stratified sampling will ascertain that 50% of participants will have a history of checking their own skin, whilst the other 50% will have no record of SSE. All participants must be able to speak English to give informed consent. Participants must have access to a smartphone.

Exclusion Criteria

People who do not have access to an iPhone, People who have cognitive impairment that prevents them from providing informed consent, People who do not speak English for informed consent, those living outside of Queensland and not available for a visit to QUT for a skin exam.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary Outcome: Safety and feasibility of mobile teledermoscopy for Queensland residents 50-64 years of age at high risk for melanoma. A follow-up survey after their SSE to assess (1) whether they found any suspicious lesions, (2) comfort level with the procedures, smartphone and dermatoscope, (3) satisfaction with the Asymmetry and Colour (AC) Rule and materials provided, (4) mobile teledermoscopy acceptance, self-efficacy and skin cancer worry.[One month after all participants have completed their SSE.]
Secondary Outcome Measures
NameTimeMethod
Assess the findings within the context of an existing technology acceptance model, and whether the technology acceptance model explains the intentions of people to use teledermoscopy in the future as well as their actual behaviour[One month after all participants have completed their SSE.]
© Copyright 2025. All Rights Reserved by MedPath